Study of AG-270 in Participants With Advanced Solid Tumors or Lymphoma With MTAP Loss

NCT03435250 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

123

Enrollment

OTHER

Sponsor class

Stopped Strategic reasons

Conditions

Advanced Solid Tumors
Lymphoma

Interventions

DRUG: AG-270
DRUG: AG-270
DRUG: AG-270
DRUG: docetaxel
DRUG: nab-paclitaxel
DRUG: gemcitabine

Sponsor

Institut de Recherches Internationales Servier